JP2011517662A5 - - Google Patents

Download PDF

Info

Publication number
JP2011517662A5
JP2011517662A5 JP2010549807A JP2010549807A JP2011517662A5 JP 2011517662 A5 JP2011517662 A5 JP 2011517662A5 JP 2010549807 A JP2010549807 A JP 2010549807A JP 2010549807 A JP2010549807 A JP 2010549807A JP 2011517662 A5 JP2011517662 A5 JP 2011517662A5
Authority
JP
Japan
Prior art keywords
mmp
binding protein
antibody
binding
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010549807A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011517662A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/035840 external-priority patent/WO2009111450A2/en
Publication of JP2011517662A publication Critical patent/JP2011517662A/ja
Publication of JP2011517662A5 publication Critical patent/JP2011517662A5/ja
Withdrawn legal-status Critical Current

Links

JP2010549807A 2008-03-03 2009-03-03 メタロプロテアーゼ９結合タンパク質 Withdrawn JP2011517662A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US3307508P 2008-03-03 2008-03-03
US61/033,075 2008-03-03
US5493808P 2008-05-21 2008-05-21
US61/054,938 2008-05-21
US13829708P 2008-12-17 2008-12-17
US61/138,297 2008-12-17
PCT/US2009/035840 WO2009111450A2 (en) 2008-03-03 2009-03-03 Metalloproteinase 9 binding proteins

Publications (2)

Publication Number Publication Date
JP2011517662A JP2011517662A (ja) 2011-06-16
JP2011517662A5 true JP2011517662A5 (https=) 2012-04-19

Family

ID=41056597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549807A Withdrawn JP2011517662A (ja) 2008-03-03 2009-03-03 メタロプロテアーゼ９結合タンパク質

Country Status (6)

Country Link
US (2) US8008445B2 (https=)
EP (1) EP2262529A4 (https=)
JP (1) JP2011517662A (https=)
AU (1) AU2009222048A1 (https=)
CA (1) CA2717576A1 (https=)
WO (1) WO2009111450A2 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635588C (en) 2005-12-30 2015-11-10 Dyax Corp. Metalloproteinase binding proteins
WO2009079581A1 (en) 2007-12-17 2009-06-25 Dyax Corp. Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
AU2008338421A1 (en) 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
AU2009221916A1 (en) 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2009111450A2 (en) 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 binding proteins
WO2011028883A2 (en) * 2009-09-03 2011-03-10 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2011084749A1 (en) * 2009-12-21 2011-07-14 The Research Foundation Of State University Of New York Compositions and methods for inhibiting mmp-9-mediated cell migration
US20130142734A1 (en) * 2010-01-12 2013-06-06 Ayelet David Targeted delivery systems for diagnostic applications
US8697078B2 (en) * 2010-01-27 2014-04-15 Yeda Research And Development Co. Ltd. Antibodies that inhibit metalloproteins
WO2011109738A1 (en) * 2010-03-05 2011-09-09 The Curators Of The University Of Missouri Biomarkers of osteoarthritis
WO2011133555A2 (en) 2010-04-20 2011-10-27 The Research Foundation Of State University Of New York Compositions and methods for inhibiting matrix metalloproteinase (mmp)-mediated cell migration
WO2012027127A2 (en) * 2010-08-23 2012-03-01 The Ohio State University Research Foundation Elisa for haptoglobin-matrix metalloproteinase 9 complex as a diagnostic test for conditions including acute inflammation
CN105044349B (zh) 2010-08-26 2018-04-06 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
KR101930179B1 (ko) * 2010-08-27 2018-12-17 길리아드 바이오로직스, 인크. 매트릭스 메탈로프로테이나제 ９에 대한 항체
AU2015201367B2 (en) * 2010-08-27 2016-12-15 Gilead Sciences, Inc. Antibodies to matrix metalloproteinase 9
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein
NZ629178A (en) * 2012-02-29 2016-09-30 Gilead Biologics Inc Antibodies to matrix metalloproteinase 9
AU2012318302C1 (en) * 2012-02-29 2017-06-15 Gilead Biologics, Inc. Antibodies to matrix metalloproteinase 9
PL3489261T3 (pl) 2012-08-24 2021-08-16 The Regents Of The University Of California Przeciwciała i szczepionki do stosowania w leczeniu nowotworów z ekspresją ROR1 i w hamowaniu przerzutu
JP6799201B2 (ja) 2013-07-31 2020-12-16 アヴァリン ファーマ インク． エアロゾルチロシンキナーゼ阻害剤の化合物、及びその使用
KR20150029457A (ko) * 2013-09-10 2015-03-18 삼성전자주식회사 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도
FR3015986A1 (fr) * 2013-12-30 2015-07-03 Lvmh Rech Aptameres inhibiteurs de l'activite enzymatique de la proteine mmp-9
EA201691414A1 (ru) * 2014-02-27 2017-03-31 Джилид Сайэнс, Инк. Антитела к матриксной металлопротеиназе 9 и способы их применения
EP2985295A1 (en) * 2014-08-13 2016-02-17 Calypso Biotech SA Antibodies specific for MMP9
EP2985296A1 (en) * 2014-08-13 2016-02-17 Calypso Biotech SA Antibodies specific for MMP9
CR20180177A (es) 2015-09-30 2018-06-22 Janssen Biotech Inc Anticuerpos agonistas que se unen específicamente a cd40 humana y método de uso
JP2016106147A (ja) * 2016-03-14 2016-06-16 ギリアード バイオロジックス， インコーポレイテッド マトリックスメタロプロテイナーゼ９に対する抗体
US20200306283A1 (en) 2016-06-22 2020-10-01 William Warren HARLESS Cancer treatment and metastasis inhibition using an anti-cancer stem cell agent in combination with a neu1 sialidase inhibitor or a cytokine inhibitor after primary cancer treatment
IL299099B2 (en) 2016-06-27 2025-07-01 Univ California Cancer treatment combinations
WO2018129090A1 (en) * 2017-01-03 2018-07-12 Trellis Bioscience, Llc Native human antibodies for immune checkpoint modulation targets tim-3 and b7-h3
US20230074615A1 (en) * 2019-05-21 2023-03-09 The Regents Of The University Of California Mmp-9 antibodies and methods of use thereof
WO2022170126A2 (en) * 2021-02-05 2022-08-11 Adagio Therapeutics, Inc. Compounds specific to coronavirus s protein and uses thereof
JP7474736B2 (ja) * 2021-12-27 2024-04-25 花王株式会社 白斑の予防又は改善剤の評価又は選択方法
CN120230208A (zh) * 2024-08-07 2025-07-01 上海交通大学医学院附属第九人民医院 一组sh23同源簇全人源tsh受体阻断性单克隆抗体及其制备方法和应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0736302A3 (en) * 1995-03-23 1997-06-04 Stichting Rega V Z W Protease inhibitors, DNA construction for protease expression and a method for measuring proteases and / or protease inhibitors
GB9809764D0 (en) 1998-05-07 1998-07-08 Isis Innovation MMP-9 Gene polymorphisms
CN1379685A (zh) * 1999-07-13 2002-11-13 南加利福尼亚大学 用基于MMP－9和β1整联蛋白的拮抗剂抑制血管发生的新方法和组合物
US7101975B1 (en) * 1999-07-13 2006-09-05 University Of Southern California Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins
WO2001026671A1 (en) 1999-10-12 2001-04-19 Smithkline Beecham Corporation Methods of treatment using dual matrix-metalloproteinase-2 and matrix metalloproteinase-9 inhibitors
US6573096B1 (en) * 2000-04-01 2003-06-03 The Research Foundation At State University Of New York Compositions and methods for inhibition of cancer invasion and angiogenesis
EP1297112A2 (en) * 2000-05-22 2003-04-02 PHARMACIA & UPJOHN COMPANY Novel matrix metalloproteinases
AR028606A1 (es) 2000-05-24 2003-05-14 Smithkline Beecham Corp Nuevos inhibidores de mmp-2/mmp-9
KR100919593B1 (ko) 2000-06-29 2009-09-29 아보트 러보러터리즈 이중 특이성 항체 및 이의 제조 방법 및 이를 포함하는 조성물
AU2001289930A1 (en) * 2000-09-25 2002-04-08 Rega Stichting Vzw Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis
US20070258987A1 (en) * 2000-11-28 2007-11-08 Seattle Genetics, Inc. Recombinant Anti-Cd30 Antibodies and Uses Thereof
AU2002235692A1 (en) * 2001-02-23 2002-09-04 Biophage Inc. Methods and compositions for preventing and treating neutrophil-mediated diseases
ATE458199T1 (de) * 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
AU2002352089A1 (en) * 2001-11-23 2003-06-10 Universite Catholique De Louvain Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis
AU2003274059A1 (en) 2002-10-23 2004-05-13 F. Hoffmann-La Roche Ag Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof
ES2433440T3 (es) 2003-04-04 2013-12-11 Yeda Research And Development Co. Ltd. Anticuerpos contra MMP2 o MMP9 y composiciones farmacéuticas que contienen los mismos útiles para inhibir la actividad de dichas metaloproteínas
US7435800B2 (en) * 2003-05-23 2008-10-14 Chi-Mei Medical Center Antibodies to interleukin-20 and method for inhibiting interleukin-20 induced cell proliferation
US20050118632A1 (en) * 2003-11-06 2005-06-02 Jian Chen Polynucleotides and polypeptides encoding a novel metalloprotease, Protease-40b
US20060002969A1 (en) * 2004-01-27 2006-01-05 University Of Washington Methods for reducing the foreign body reaction
FI20040572A0 (fi) * 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
CN100497324C (zh) 2004-05-27 2009-06-10 武汉科艾硒医药科技发展有限公司 具有抗纤维化及抑制明胶酶活性的化合物及其应用
WO2006036928A2 (en) 2004-09-27 2006-04-06 Wayne State University Inhibitors of matrix metalloproteinases to treat neurological disorders
US20080254490A1 (en) 2005-02-02 2008-10-16 Ramkumar Menon Salivary Protease Assays for Identifying Increased Risk of Preterm Delivery Induced by Premature Rupture of Fetal Membranes
DE102005015040A1 (de) 2005-03-31 2006-10-05 Sanofi-Aventis Deutschland Gmbh Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
EP1931632A4 (en) * 2005-08-18 2011-05-11 Microbia Inc USEFUL INDOOR CONNECTIONS
US8092819B2 (en) * 2006-01-27 2012-01-10 Cook Medical Technologies LLC. Implantable medical device coated with a bioactive agent
WO2007149948A2 (en) 2006-06-20 2007-12-27 The Gov. Of The Usa As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for diagnosis and treatment of tumors
DK2185175T3 (da) * 2007-08-15 2013-05-13 Yeda Res & Dev MMP-9-regulatorer og anvendelser deraf
KR20090034637A (ko) 2007-10-04 2009-04-08 엘지전자 주식회사 차량용 거치대
AU2008338421A1 (en) * 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
WO2009079581A1 (en) * 2007-12-17 2009-06-25 Dyax Corp. Evaluating mmp expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancer
AU2009221916A1 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins
WO2009111450A2 (en) 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 binding proteins
WO2010045388A2 (en) 2008-10-14 2010-04-22 Dyax Corp. Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis
EP2350305A4 (en) 2008-10-22 2013-03-06 Dyax Corp COMBINATION TREATMENTS WITH PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISEASES
WO2011028883A2 (en) 2009-09-03 2011-03-10 Dyax Corp. Metalloproteinase 9 and metalloproteinase 2 binding proteins

Similar Documents

Publication Publication Date Title
US8013125B2 (en) Metalloproteinase 9 and metalloproteinase 2 binding proteins
US8008445B2 (en) Metalloproteinase 9 binding proteins
JP2011517662A5 (https=)
JP2011517320A5 (https=)
US8114968B2 (en) Metalloproteinase-12 specific monoclonal antibody
US20110135573A1 (en) Metalloproteinase 9 and metalloproteinase 2 binding proteins
US12350347B2 (en) Nucleic acids encoding anti-IL1RAP antibodies and their uses
AU2011204349C1 (en) Plasma kallikrein binding proteins
CN110078827A (zh) 结合表皮生长因子受体的可活化的抗体其使用方法
US11981732B2 (en) Anti-TMEFF1 antibodies and antibody drug conjugates
WO2009097397A2 (en) Metalloproteinase binding proteins
WO2010045388A2 (en) Use of mmp-9 and mmp-12 binding proteins for the treatment and prevention of systemic sclerosis
AU2019204295A1 (en) Plasma kallikrein binding proteins